Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (7832)	2/6/2003 11:40:14 AM
From: Biomaven	Read Replies (1) \| Respond to of 52153

tuck, For quite a time now, shorting biotechs has not been risky. CEPH jumping like this after bad (albeit expected) news puts some of the risk back into the shorters' equation. SCIO seems to be shrugging off its own bear attack as well - once the reason for the short-term decline was revealed (an abstract with a negative-sounding title) the stock has been strong. In the cases of both CEPH and SCIO, the major brokerage firms jumped in with support - also something that has been lacking for a while. Bottom line is that I feel a firmer underlying tone in the biotechs. Won't help much if the overall market cracks, though. Peter